The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Primary CNS Lymphoma: High-Dose Methotrexate-Based Therapy

Aggressive extranodal lymphoma confined to brain, spinal cord, leptomeninges or eyes requiring CNS-penetrating chemotherapy

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Primary CNS Lymphoma: High-Dose Methotrexate-Based Therapy?

Primary CNS lymphoma represents 4% of brain tumors and 1% of non-Hodgkin lymphomas with rising incidence in immunocompetent older adults.

Histology is predominantly diffuse large B-cell lymphoma with activated B-cell subtype and frequent MYD88 and CD79B mutations.

HIV-associated PCNSL universally Epstein-Barr virus driven differs from immunocompetent disease in pathobiology and clinical features.

Diagnosis requires stereotactic brain biopsy after corticosteroid avoidance to preserve diagnostic yield in high-grade lymphoma.

Staging includes brain MRI, ophthalmologic examination including slit lamp, lumbar puncture for cytology and flow cytometry plus bone marrow assessment.

Symptoms

Cognitive changes including memory difficulties, executive dysfunction and personality changes occur in most patients reflecting white matter involvement.
Focal neurological deficits depend on lesion location with hemiparesis, aphasia, visual field defects and ataxia all possible.
Headaches with progressive features and signs of increased intracranial pressure may indicate large or strategic lesions.
Seizures occur in approximately 10-15% of patients particularly with cortical lesion involvement.
Ocular involvement may present with floaters, blurred vision or uveitis-like presentations preceding or accompanying CNS disease.

Risk Factors

Immunosuppression including HIV/AIDS, post-transplant or congenital states markedly increases risk with EBV-driven pathobiology.
Advanced age, male sex and white race demonstrate epidemiologic associations though disease occurs across demographics.
Autoimmune disease and immunosuppressive therapy may modestly increase risk reflecting altered immune surveillance.
No definitive environmental or lifestyle risk factors have been identified for sporadic immunocompetent PCNSL.
Genetic predisposition appears modest though familial clustering has been reported in occasional cases.

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Subacute progressive cognitive change, personality alteration or new neurological deficits warrant urgent neurologic evaluation.
  • New seizure onset particularly in middle-aged or older adults requires comprehensive evaluation including brain imaging.
  • Ocular floaters or vision changes with abnormal slit lamp findings may indicate vitreoretinal lymphoma involvement.
  • Imaging findings of homogeneously enhancing periventricular or deep brain lesions raise PCNSL concern requiring tissue diagnosis.
  • Hematology-oncology and neuro-oncology referral coordinates multidisciplinary diagnostic workup and treatment planning.

Treatment Methods

01
High-dose methotrexate at 3-8 g/m² with leucovorin rescue forms backbone of induction therapy combined with rituximab.
02
Multi-agent regimens including R-MPV, MATRix or similar combine methotrexate with cytarabine, thiotepa and rituximab for induction.
03
Consolidation strategies include high-dose chemotherapy with autologous stem cell transplantation, low-dose whole-brain radiotherapy or non-myeloablative chemotherapy.
04
Maintenance approaches with lenalidomide or other agents may improve durability though optimal strategies remain under investigation.
05
Long-term follow-up monitors for relapse, late neurotoxicity, secondary malignancies and quality of life with cognitive assessment supporting comprehensive survivorship care for this challenging disease.

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.